Purpose: Evaluate the effects of iloprost administration in the early period of ischemic colitis and the mechanism that how these effects develop. Methods: Thirty two Wistar albino female rats with an average weight of 220g were divided into four groups of eight rats. In group 1 the rats were given iloprost and sacrificed after 24 hours and in group 2 they were sacrificed after 24 hours without any iloprost. The rats in group 3 were administrated iloprost and sacrificed after 72 hours and in group 4 they were sacrificed at 72 th hour without iloprost. The differences between the groups as tissue damage, vascularization or apoptosis were assessed statistically. Results: Oxidative damage and apoptosis were less pronounced and vascularization was better developed in rats that were given iloprost and sacrificed at 24 th hour later in contrast to the rats that were not treated with iloprost. But there was no statistical difference among the groups at 72 th hour. Conclusion: Iloprost inhibited leucocyte infiltration, decreased proinflammatory cytokines and enhanced angiogenesis so that the oxidative stress and inflammatory response decreased resulting in lesser tissue damage. Key words: Colitis, Ischemic. Iloprost. Epoprostenol. Arachidonic Acid. Prostaglandins. Rats.
Introduction
Ischemic colitis is the tissue damage and inflammation that occurs as a result of insufficient blood supply to the colon and it was reported for the first time by Boley et al. 1 almost 90%
of the cases are 60 years or older but it can also occur in younger people. Since it may be self limiting and the diagnosis is usually made by suspicion the exact incidence can not be estimated.
The insufficient blood supply may be due systemic circulatory abnormalities that induce hypo-perfusion such as congestive heart failure or shock but it may also due to local factors like mesenteric vasoconstriction or obstruction as well. The clinical picture may vary from abdominal distention to acute abdomen. Mild cases may respond to bowel rest, intravenous hydration and antibiotics but severe cases may result in intestinal gangrene, perforation and sepsis.
There is yet no effective treatment modality neither in ischemic nor ischemia-prone cases.
Iloprost is a synthetic stable long acting prostacyclin (PGI2) analogue that exerts its effects in the endothelium.
Within normal blood pressure range it has a selective mesenteric vasodilatator effect 2 . The half life of iloprost is 4 minutes and it has an elimination duration of 30 minutes. It decreases the thrombocyte aggregation, leukocyte activation and chemotaxis and suppresses the superoxide anion production. It is also a potent vasodilatator. Manasia et al. 3 reported that low dose (0.075µg/ kg/min) iloprost increased the superior mesenteric blood flow in a systemic hypotension model cused by septic shock. Iloprost was also reported to have liver and kidney sparing properties in ischemia-reperfusion damage 4, 5 . In patients with critical limb ischemia iloprost increased the endothelial progenitor cells in vivo and induced angiogenesis 6 . Iloprost was also reported by Lehman et al. 7 that it has a protective effect against endotoxin induced intestinal damage in rats and that was attributed to the decrease in leucocyte adhesion in the circulation and decrease in oxitadive damage by inhibition of proinflammatory cytokines such as TNFalpha and IL-6
.
It is also reported that prostacyclin has stimulatory effects on angiogenesis 10 . The angiogenic function of the human endotalial progenitor cells (EPG) is closely associated with the arachiadonic acid metabolism and prostocylin biosynthesis.The in vivo and in vitro angiogenic capacity of EPG was shown to be related with the endogenous prostocylin levels produced by EPG
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Iloprost is reported in the literature as it has protective effects on tissue damage by the way that it induces angiogenesis and is cytoprotective, increases intestinal blood flow and diminishes neutrophil aggreagation. But there is no study yet that explored its clinical or experimental effects on ischemic colitis.
We aimed to study the effects and the mechanisms of action of the early administration of iloprost on ischemic colitis.
Methods
The study was approved by the ethical committee for the research on the animals and run in the laboratories for experimental research in Istanbul University between October 2009 and January
2010.
Thirty two Wistar albino female rats with an average weight of 220g were used in the study. They were kept in individual cages for 12 hours day and 12 hours night pattern and were fed normal diet in the pre-and postoperative period.
The rats were randomized into 4 groups so that each group has 8 rats and ischemic colon was formed in each rat.
Group 1: rats were given iloprost and were sacrificed at 24 th hour.
Group 2: rats were sacrificed at 24 th hour but not given iloprost.
Group 3: rats were given iloprost and were sacrificed at 72 th hour.
Group 4: rats were sacrificed at 72 th hour but not given iloprost.
The rats were put under anesthesia by giving 10mg/ kg ketamine injection intraperitoneally. The incision site was shaved and cleaned by 10% poviodine-iodine solution. Following laparatomy the ischemic colon was formed by ligating and cutting the vessels in the mesenteric tissue supplying about 2 to 4 cm. area of the distal colon. Rats in group 1 and 2 were subjected to 2µg/kg iloprost (Iloprost 20µg/ml; Schering, Berlin) by intravenous infusion.
The rats in groups 1 and 2 were sacrificed at 24 th hour and the rats in groups 3 and 4 were sacrificed at 72 th hour. Tissue was sampled from the experimental ischemic colon for biochemical and histopathological study.
Iloprost therapy
The treatment dosage of the iloprost in the treatment of ischemic colitis is not present in the literature. The dosage was calculated by reviewing literature about the amount of iloprost that was effective on the ischemic tissue and the amount was given as a single dose after the surgery iloprost was administrated in the early period after the laparatomy to the rats in groups 1 and 3 12, 13 .
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The assessment of the oxidative damage

The measurement of nitric-oxide (NO)
NO was calculated by the calorimetric method (Boehringer Mannheim Kit; Kat no: 01756281). The normal value for NO within tissues was accepted as <0.5pg/mg.
The measurement of vascular endothelial growth factor (VEGF)
The plates coated with antipoliclonal animal VEGF were used and the tests were performed by automatic Best 2000 (Biokit)
microelisa. The normal value of VGEF in the tissue was accepted <50pg/mL/mg.
The measurements of tumor necrosis factor -alpha (TNFα) and interleukin-6 (IL6)
The levels of TNFα ang IL6 within the homogenate were calculated by ELISA (Quantikene-Sensitivity-Human by RPD systems, USA). The normal value of TNFα was accepted as <3.5ng/mg and of IL6 as <3.0pg/mg.
Histopathological assessments
The tissue samples were fixed in 10% formaldehyde and 
Statistical evaluation
The results were assessed as mean and standard deviation. 
Results
No mortality occurred among the study animals. The rats were sacrificed 24 and 72 hours after the performance of colonic ischemia. Biochemical values and comparisions were given as tables.
When biochemical data were analyzed the differences in the levels of TNFα and IL6 were found to be statistically significant (p=0.029 for both). MDA and NO levels as the important parameters of oxidative damage were significantly different in group 1 in contrast to group 2 (p=0.001 and p=0.002).
Also the levels of VEGF at 24 th hour was significant in group 1 in contrast to group 2 ( Table 1) . 
Histopathological results
The tissues were analyzed by an independent blinded pathologist. Epithelization, monocyte and neutrophil infiltration, necrosis and capillary proliferation were assessed. All the parameters were statistically higher in group 1 compared to group 2 (monocyte infiltration p=0.020, neutrophil infiltration p=0.42, capillary proliferation p=0.001) (Figures 1 and 2 ) ( Table 3) . Mortality may be 50 to 80% even with the best treatment. The recovery of the oxygen supply to the ischemic colon is the main aim during the therapy. In addition to the normal vascular supply promotion of the angiogenesis to the ischemic wound healing is necessary and can be observed by the levels of the VEGF in the molecular level. Di Stefano et al. 6 reported that iloprost increased the levels of VEGF and promoted the angiogenesis in vivo so that the progenitor endothelial cell number expanded and ischemic limbs showed clinical improvement. We found that early administration of iloprost enhanced VEGF production in the tissue and there was a statistically significant increase compared to the control group (group 1 with iloprost therapy after ischemia vs. group 2 without iloprost therapy) (p=0.002) but there was no difference after 72 hours (p=0.6) Histopathologically increased levels of vascularization was observed in group 1 at 24 th hour that and although the increase was sustained even at 72 hours it was not statistically significant.
When the ischemia advances the mediators are secreted at the cellular level that result in tissue injury and oxidative damage. The cells proceed to the apoptosis which is a programmed cellular death required for physiologic homeostasis 16 . Bortoletto et al. 17 claimed that ischemia increases apoptosis during intestinal ischemia and hyperbaric oxygen therapy cam protect the mucosa against the ischemia-reperfusion injury. Similarly Aslan et al reported that there is increased inflammation and apoptosis in ischemic bowel anostomoses and meselamine (5-ASA) administration decreased the inflammation in the ischemic area by suppressing the free oxygen radicals 18 . We found too that inflammation, oxidative damage and apoptosis is increased in ischemia produced rats. To survey the level of apoptosis at the tissue level the caspase-3 levels were assessed by biochemical methods. The caspase family activates a broad spectrum of genes that play a role in the synthesis of proinflammatory cytokines and acute phase proteins. In addition caspase-3 activity can use as a measure of apoptozis 19 . The caspase-3 activity was significantly different in iloprost given group 1 at 24 th hour compared to the control group 2 but this difference disappeared at 72 th hour. This can be translated that iloprost decreases the apoptosis in the early period of ischemia. Apoptozis is a complex process but we failed to prove the exact mechanism how the iloprost produced anti-apopitotic activity. The anti-inflammatory mechanism, increased vasculariztion or antioxidative protection all may play a role. Manasia et al. 3 showed that administration of 0.18µg/kg/ min iloprost to the pigs subjected to septic shock increased the mesenteric perfusion without affecting mean arterial pressure by increasing cardiac output and increasing superior mesenteric artery blood flow. The same study also gave the information that the inflammation produced by endotoxic shock was diminidhed wit the use of iloprost. We found histopathologically that inflammatory cell activation was lower and enhancement of vasculariztion was better in the iloprost givengroup. The results were supported by biochemical survey and early administration of iloprost was proven even to be futher effective.
Iloprost is long acting stable prostacycline (PGI2)
analogue. PGI2 is an endothelial cyclooxygenase function product that decreases thrombocyte aggregation, leucocyte activation, chemotaxis and superoxide anion production. It is a potent vasodilatator 20 by relaxing the vascular tone it prevents vascular obstruction and helps the vessels carry more blood to the tissue.
Iloprost decreases the blood viscosity, dissolves plugs and prevents aggregation of shed off endothelial cells 21, 22 . Prostaglandins enhance the blood flow in ischemia-reperfusion injury in skeletal muscles
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. Iloprost had therapeutic effects compared to placebo administratin in patients with diabetic feet ulcers [23] [24] [25] . The patients complained lesser pain and improved ulcers with clinically proven decrease in the risk of amputation both during the teherapy and also in the 3-6 month follow-up period after the treatment 26 .
Iloprost and propentoxyphylinne reduces the macrophage produced IL6 and TNFα [27] [28] [29] [30] [31] [32] . It coordinates the production of genes that control cellular growth and inflammation and decreases productions of cytokines in vitro. In addition to its vasodilatator and antiaggregating effects, it may also has anti-inflammatory
. Iloprost can be administrated as through inhalational route or by intravenous infusion 34 . The requisite for infusion makes patient compliance difficult and inpatient treatment is required 34, 35 .
We introduced iloprost intreperitoneally at a dose of 2µg/kg/min since it is very difficult to infuse the drug intravenously for a long time in rats. K.Vasiliadis also used the drug intraperitoneally at the same dosage to counteract the side effects of the chemotherapeutic agents and to improve the healing of the colonic anastomoses 12 .
We had set forth the study by reviewing the literature for the beneficial effects of iloprost and conclude that it has diminished the oxidative damage, decreased proinflammatory cytokines but enhanced angiogenesis so that it has especially prevented the ischemic damage in the early period histopathologically. The main shortfall of the study is that we could not identify the mechanisms by which the iloprost produced its protective effects. 
Conclusions
